<div id="readability-page-1"><p>Hinge Health Inc. (NYSE:HNGE - Get Free Report) was the recipient of a significant increase in short interest in December. As of December 15th, there was short interest totaling 4,180,660 shares,  an increase of 117.4% from the November 30th total of 1,922,965 shares. Based on an average daily trading volume, of 1,473,836 shares, the days-to-cover ratio is presently 2.8 days. Approximately 5.3% of the company's shares are short sold. Approximately 5.3% of the company's shares are short sold. Based on an average daily trading volume, of 1,473,836 shares, the days-to-cover ratio is presently 2.8 days.</p><h2>Insider Activity at Hinge Health</h2><p>In related news, CEO Daniel Antonio Perez sold 166,670 shares of the company's stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $48.53, for a total value of $8,088,495.10. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO James Budge sold 44,589 shares of the firm's stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $47.47, for a total value of $2,116,639.83. Following the sale, the chief financial officer directly owned 479,878 shares of the company's stock, valued at approximately $22,779,808.66. This trade represents a 8.50% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 2,638,440 shares of company stock valued at $120,486,691 in the last three months. </p><h2>Institutional Investors Weigh In On Hinge Health</h2><p>Large investors have recently modified their holdings of the company. Sandler Capital Management grew its stake in shares of  Hinge Health by 1.4% during the third quarter. Sandler Capital Management now owns 52,728 shares of the company's stock worth $2,588,000 after purchasing an additional 728 shares in the last quarter.  Mirae Asset Global Investments Co. Ltd. purchased a new stake in  Hinge Health during the 3rd quarter worth about $37,000.  Montag A &amp; Associates Inc. acquired a new position in shares of  Hinge Health during the 2nd quarter worth about $41,000.  Jones Financial Companies Lllp increased its holdings in shares of  Hinge Health by 348.0% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company's stock valued at $54,000 after acquiring an additional 870 shares during the last quarter.  Finally, SBI Securities Co. Ltd. acquired a new stake in shares of  Hinge Health during the 2nd quarter worth about $48,000. </p><h2>Analyst Upgrades and Downgrades</h2><p>A number of research firms have recently weighed in on HNGE. Wall Street Zen upgraded Hinge Health from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday, December 20th. Weiss Ratings  reiterated a &#34;sell (d)&#34; rating on shares of Hinge Health in a research report on Wednesday, October 8th. Evercore ISI boosted their price target on shares of Hinge Health from $60.00 to $65.00 and gave the company an &#34;outperform&#34; rating in a research note on Wednesday, October 8th. Baird R W raised shares of Hinge Health to a &#34;hold&#34; rating in a research report on Friday, September 5th. Finally, Barclays lifted their target price on shares of Hinge Health from $62.00 to $65.00 and gave the company an &#34;overweight&#34; rating in a report on Wednesday, November 5th. One equities research analyst  has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, two have given a Hold rating and one  has assigned  a Sell rating to the company's stock. Based on data from MarketBeat.com, Hinge Health  has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $59.93.</p><p><b>Get Our Latest Research Report on HNGE</b></p><h2>Hinge Health Price Performance</h2><p>NYSE HNGE opened at $47.57 on Friday. The firm has a 50 day simple moving average of $47.59 and a 200-day simple moving average of $49.34. Hinge Health has a one year low of $33.42 and a one year high of $62.18. </p><p>Hinge Health (NYSE:HNGE - Get Free Report) last posted its quarterly earnings data on Tuesday, November 4th. The company reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.20) by $0.18. The company had revenue of $154.21 million for the quarter, compared to analysts' expectations of $142.44 million. The firm's quarterly revenue was up 53.3% compared to the same quarter last year. </p><p>Hinge Health announced that its board has authorized a share buyback program on Wednesday, November 12th that permits the company to buyback $250.00 million in  outstanding  shares. This buyback authorization permits the company to purchase up to 7.2% of its stock  through open market purchases. Stock  buyback programs are usually a sign that the company's board believes its shares are undervalued. </p><h2>Hinge Health Company Profile</h2> (Get Free Report)<p>Hinge Health <span>NYSE: HNGE<span></span></span> is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.  </p><p>Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Hinge Health</li><li>Do not delete, read immediately</li><li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li><li>Can Any Expenses Be Deducted From Capital Gains Tax?</li><li>Do you know what Amazon is planning for January 1?</li><li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Hinge Health Right Now?</h2><p>Before you consider Hinge Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.</p><p>While Hinge Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

HNGE

<p>Hinge Health Inc. (NYSE:HNGE) saw a 117.4% increase in short interest in December, totaling 4,180,660 shares. The days-to-cover ratio is 2.8 days. CEO Daniel Perez and CFO James Budge sold significant shares recently. Institutional investors adjusted their holdings, with some increasing stakes. Analysts have mixed ratings, with a consensus of "Moderate Buy" and a price target of $59.93. The stock opened at $47.57, with a 50-day average of $47.59 and a 200-day average of $49.34.</p>

Hinge Health Inc. (NYSE:HNGE) Short Interest Update